摘要
目的:评价氯沙坦对急性心肌梗死泵功能不全患者的治疗作用。方法:79例急性心肌梗死并泵功能不全患者随机分为氯沙坦组(A组)和培哚普利组(B组),在按急性心肌梗死基本治疗方案的基础上,A组加用氯沙坦50mg,每日1次,B组加用培哚普利2~4mp,每日1次。观察4周。结果:氯沙坦治疗急性心肌梗死患者泵功能不全与培哚普利相似,减少心律失常发生率的作用及不良反应优于培哚普利。结论:氯沙坦是治疗急性心肌梗死泵功能不全的有效药物。
Objective: To evaluate the efficacy of Losartan in the treatment of AMI patients complicated with pump failure.Methods:79 cases were randomized divided into two group.On the base treatment of acute myocardial infarction,patients in group A were given Losartan 50mg daily while perindopril 2mg to 4mg daily in group B. The course of study was 4 weeks. Results: The clinical efficacy of Losartan were similar to perindopril in AMI patients complicated with pump failure,with a lower incidence of adverse effect than control. Conclusion: This study verified that Losartan is a effective drug in the treatment of AMI complicatedwith pump failure.
出处
《广州医药》
2000年第3期10-11,共2页
Guangzhou Medical Journal